TEVA-IPRATROPIUM STERINEBS
TEVA-IPRATROPIUM STERINEBS
Approved
DIN Number
02216221
Drug Class
Human
Market Date
Mar 4, 1998
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02216221
AIG Number0115643001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BB01 IPRATROPIUM BROMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationInhalation
AHFS Classification12:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
IPRATROPIUM BROMIDEActive
Strength: 250 MCG / ML
Monograph: IPRATROPIUM BROMIDE